Takeda Gmbh
SpainAll drugs from this manufacturer
-
It is used to treat diseases related to stomach and intestinal acid, such as gastroesophageal reflux (heartburn, acid regurgitation, or pain when swallowing), reflux esophagitis, and to prevent ulcers in the stomach or duodenum in people who must take anti-inflammatory drugs (NSAIDs) on a continuous basis.
Dosage form: tablets, enteric-coated
Active substance Dosage pantoprazole sodium sesquihydrate 22,6 mg -
It is used to treat conditions related to excess acid in the stomach and intestine, such as reflux esophagitis, stomach and duodenal ulcers, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome.
Dosage form: tablets, enteric-coated
Active substance Dosage pantoprazole sodium sesquihydrate 45,10 mg -
It is used to treat diseases related to excess acid in the stomach and intestine in adults, such as reflux esophagitis, stomach and duodenal ulcers, and Zollinger-Ellison syndrome.
Dosage form: powder for solution for injection
Active substance Dosage pantoprazole sodium sesquihydrate 40 mg -
It is used to treat conditions related to stomach and intestinal acid, such as heartburn, acid regurgitation, and pain when swallowing associated with gastroesophageal reflux disease. It is also used to treat reflux esophagitis and to prevent stomach or duodenal ulcers in adults who must take anti-inflammatory drugs (NSAIDs) on a continuous basis.
Dosage form: tablets, enteric-coated
Active substance Dosage pantoprazole sodium sesquihydrate 22,57 mg -
It is used to treat diseases related to excess acid in the stomach and intestine, such as reflux esophagitis, stomach and duodenal ulcers, Zollinger-Ellison syndrome, and Helicobacter pylori infection (in combination with antibiotics).
Dosage form: tablets, enteric-coated
Active substance Dosage pantoprazole sodium sesquihydrate 45,10 mg -
It is used to help protect adults, adolescents, and children (from 4 years of age) against dengue, a disease caused by four serotypes of the dengue virus.
Dosage form: powder and solvent for solution for injection
Active substance Dosage dengue virus live attenuated serotype 1 ≥ 3,3 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) dengue virus live attenuated serotype 2 ≥ 2,7 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) dengue virus live attenuated serotype 3 ≥ 4 log10 Unidades formadoras de placa/dosis (UFP/DOSIS) dengue virus live attenuated serotype 4 ≥ 4,5 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)